Intravenous Albumin Should NOT Be Used to Correct Hypoalbuminemia in Most Patients
In critically ill patients who cannot take oral protein, intravenous albumin is NOT recommended for correcting low serum albumin levels, as it does not improve mortality, morbidity, or quality of life outcomes 1. This represents a conditional recommendation based on moderate-quality evidence from the 2024 International Collaboration for Transfusion Medicine Guidelines.
Why IV Albumin Doesn't Work for Hypoalbuminemia
The fundamental problem is that hypoalbuminemia is a marker of severe illness, not a treatable deficiency. While IV albumin will temporarily raise serum albumin levels, this does not translate to clinical benefit 2, 3. The underlying disease process—whether sepsis, inflammation, or critical illness—continues to drive albumin loss and suppressed synthesis regardless of infusion.
Key evidence:
- A randomized controlled trial in hypoalbuminemic patients receiving total parenteral nutrition showed that 25g daily albumin infusions raised serum levels but did not reduce mortality, sepsis, bacteremia, or pneumonia 2
- Albumin metabolism rates in critically ill patients are extremely high (17-20 g/day), meaning infused albumin is rapidly catabolized 2
- The practice wastes approximately $130 per 25g dose without improving outcomes 1
Specific Exceptions Where IV Albumin IS Indicated
Cirrhosis-Related Complications (Strong Evidence)
- Large-volume paracentesis (>5L): Give 6-8 g albumin per liter of ascitic fluid removed to prevent post-paracentesis circulatory dysfunction 4
- Spontaneous bacterial peritonitis: 1.5 g/kg at diagnosis, then 1 g/kg on day 3 4
- Hepatorenal syndrome (HRS-AKI): 1 g/kg daily for 2 days (maximum 100 g/day) combined with vasoconstrictors 4, 5
Severe Burns (After 24 Hours)
Target plasma albumin of 2.5 ± 0.5 g/dL using 25% albumin solution 5. Administer at rates not exceeding 2 mL/minute to avoid pulmonary edema.
Neonatal Hemolytic Disease
1 g/kg body weight given 1 hour before exchange transfusion to bind free bilirubin 5
What to Do Instead
Address the underlying cause rather than the albumin number:
Optimize nutrition: Provide adequate protein/amino acids enterally or parenterally (albumin infusion is NOT nutritional therapy) 5, 3
Treat the primary disease: Sepsis, inflammation, liver disease, protein-losing states
For volume resuscitation: Use crystalloids (normal saline, lactated Ringer's) as first-line—they are equally effective and far less expensive 1
For refractory edema with profound hypoalbuminemia: Consider 100 mL of 25% albumin with loop diuretics only in highly selected cases (e.g., acute nephrosis unresponsive to other therapy), but this remains controversial 5, 6
Critical Pitfalls to Avoid
Do not use albumin as a "nutritional supplement" in chronic conditions like cirrhosis, malabsorption, or malnutrition—it provides no benefit and is rapidly excreted or catabolized 5, 3
Avoid in chronic nephrosis—infused albumin is promptly excreted in urine without relieving edema 5
Watch for complications: Fluid overload, pulmonary edema (especially if infused >2 mL/min in hypoproteinemic patients), hypotension, hemodilution requiring transfusion, and rarely anaphylaxis 1, 5
Do not confuse hypoalbuminemia with hypovolemia—these require different treatments 1
Practical Dosing When Indicated
When albumin IS appropriate (cirrhosis complications, burns):
- 5% albumin solution: For volume expansion, typically 300-500 mL
- 25% albumin solution: For oncotic support, 50-100 g (200-400 mL)
- Administration rate: Maximum 2 mL/minute in hypoproteinemic patients to prevent circulatory overload 5
- Dilution: Can dilute 25% solution in 0.9% saline or 5% dextrose; use sodium-free solutions if sodium restriction needed 5
The bottom line: Treat the disease causing hypoalbuminemia, not the albumin number itself. The serum albumin level is a prognostic marker, not a therapeutic target in most clinical scenarios 7, 8.